Dergiler / Turkish Thoracic Journal / 2018 / Cilt: 19 - Sayı: 1

A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure

Sayfa
19–27
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These findings may be an important adjunct in deciding the initial antibiotic therapy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVES: Bacterial infections are the major cause of acute exacerbation of COPD (AE-COPD).
📊
Temel Bulgular & Veri:Quantitative sputum culture,blood gas analysis, and drug sensitivity testing were performed at the time of admission, and pulmonary function testing was performed 6weeks after discharge as per standard guidelines.RESULTS: Bacterial pathogens were isolated in 34 (47.22%) cases.
💡
Sonuç & Katkı:These findings may be an important adjunct in deciding the initial antibiotic therapy.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVES: Bacterial infections are the major cause of acute exacerbation of COPD (AE-COPD). The relationship between lung func-tions and respiratory failure (arterial blood gas parameters) with the etiology of AE-COPD has not been clearly understood. We conductedthis study to determine the bacterial profile in AE-COPD and to identify the associated risk factors and drug sensitivity pattern.MATERIAL AND METHODS: Seventy-two patients hospitalized for AE-COPD were prospectively evaluated. Quantitative sputum culture,blood gas analysis, and drug sensitivity testing were performed at the time of admission, and pulmonary function testing was performed 6weeks after discharge as per standard guidelines.RESULTS: Bacterial pathogens were isolated in 34 (47.22%) cases. Pathogens isolated were Pseudomonas aeruginosa (38.23%), Klebsiellapneumoniae (29.41%), Staphylococcus aureus (23.53%), Streptococcus pneumoniae (5.88%), and Acinetobacter spp. (2.94%). Isola-tion of bacterial pathogen was observed in patients with advancing age (p=0.02), frequent exacerbations (p 55 years (p=0.017) and systemic steroid use (p=0.017). Antibiotic sensitivity test-ing showed that ciprofloxacin and piperacillin/tazobactum were effective in 27/34 (79.41%) of isolates followed by gentamycin in 26/34(76%).CONCLUSION: Hypercapnic respiratory failure is an independent risk factor for isolation of K. pneumoniae and P. aeruginosa in additionto advanced age and systemic steroid use. These findings may be an important adjunct in deciding the initial antibiotic therapy.

🔖

Bu Makaleye Atıf Yap

KUWAL, A., JOSHI, V., DUTT, N., SINGH, S., AGARWAL, K. C., PUROHIT, G. (2018). A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. Turkish Thoracic Journal, Cilt: 19 - Sayı: 1, 19–27. https://ajindex.com/articles/418027

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. WHO | Burden of COPD [Internet]. WHO. [cited 2016 Feb 7]. Available from: http://www.who.int/respiratory/copd/burden/en/
  2. Jindal SK, Aggarwal AN, Gupta D, et al. Indian study on epide- miology of asthma, respiratory symptoms and chronic bronchi- tis in adults (INSEARCH). Int J Tuberc Lung Dis 2012;16:1270-7. [CrossRef] Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398-401. [CrossRef] Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702. [CrossRef] Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an ob- servational, interview-based study. Chest 2006;130:133-42. [CrossRef] White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmo- nary disease. 6: The aetiology of exacerbations of chronic ob- structive pulmonary disease. Thorax 2003;58:73-80. [CrossRef] Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83. [CrossRef] Monsó E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbat- ed outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20. [CrossRef] Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847- 52. [CrossRef] Murphy TF, Brauer AL, Grant BJ, et al. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005;172:195-9. [CrossRef] Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71. [CrossRef] Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999;116:40-6. [CrossRef] Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chron- ic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998;113:1542-8. [CrossRef] Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. [CrossRef] Murray PR, Washington JA. Micr